Cargando…
Artemisinins Target GABA(A) Receptor Signaling and Impair α Cell Identity
Type 1 diabetes is characterized by the destruction of pancreatic β cells, and generating new insulin-producing cells from other cell types is a major aim of regenerative medicine. One promising approach is transdifferentiation of developmentally related pancreatic cell types, including glucagon-pro...
Ejemplares similares
-
An inhibitor-mediated beta-cell dedifferentiation model reveals distinct roles for FoxO1 in glucagon repression and insulin maturation
por: Casteels, Tamara, et al.
Publicado: (2021) -
Single‐cell transcriptomes reveal characteristic features of human pancreatic islet cell types
por: Li, Jin, et al.
Publicado: (2015) -
A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis
por: Fauster, A, et al.
Publicado: (2015) -
Single-cell RNA-seq with spike-in cells enables accurate quantification of cell-specific drug effects in pancreatic islets
por: Marquina-Sanchez, Brenda, et al.
Publicado: (2020) -
A Target-Disease Network Model of Second-Generation BCR-ABL Inhibitor Action in Ph+ ALL
por: Rix, Uwe, et al.
Publicado: (2013)